Chemotherapy-induced insulin-dependent diabetes mellitus.
Dispenzieri
A
A
Loprinzi
C L
CL
D000932:Antiemetics / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects; D003606:Dacarbazine / Q000009:adverse effects; D003907:Dexamethasone / Q000009:adverse effects; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced*; D004317:Doxorubicin / Q000009:adverse effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects; D006801:Humans; D007580:Jejunal Neoplasms / Q000188:drug therapy*; D007890:Leiomyosarcoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000009:adverse effects
D000932:Antiemetics; D016685:Mitomycin; D003606:Dacarbazine; D003907:Dexamethasone; D004317:Doxorubicin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D002945:Cisplatin